Impact of Industry Regarding the Importance of Underrepresented & Diverse Populations in Clinical Trials

Diversity in clinical trials is a worldwide issue for enrollment, with each country having specific nuances. This session will review work conducted by SCRS in the US and around the world, including current research underway comparing UK site data from the DSAT with site data from the US. Perspectives of the research site, sponsor & CRO will be presented.